(Q47859419)

6 February 2018

title

Potent prostaglandin A1 analogs that suppress tumor cell growth through induction of p21 and reduction of cyclin E. (English)

1 reference

6 February 2018

author name string

Tanikawa M

1

1 reference

6 February 2018

Yamada K

2

1 reference

6 February 2018

Tominaga K

3

1 reference

6 February 2018

Morisaki H

4

1 reference

6 February 2018

Kaneko Y

5

1 reference

6 February 2018

Ikeda K

6

1 reference

6 February 2018

Suzuki M

7

1 reference

6 February 2018

Kiho T

8

1 reference

6 February 2018

Tomokiyo K

9

1 reference

6 February 2018

Furuta K

10

1 reference

6 February 2018

Noyori R

11

1 reference

6 February 2018

Nakanishi M

12

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 July 1998

1 reference

6 February 2018

Journal of Biological Chemistry

published in

1 reference

6 February 2018

volume

273

1 reference

6 February 2018

page(s)

18522-18527

1 reference

6 February 2018

issue

29

1 reference

6 February 2018

Human ovarian cancer cell lines resistant to cisplatin, doxorubicin, and L-phenylalanine mustard are sensitive to delta 7-prostaglandin A1 and delta 12-prostaglandin J2.

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

Modulation of human lymphocyte response to phytohemagglutinin by antineoplastic prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

Prostaglandin J2 and related compounds. Mode of action in G1 arrest and preclinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

Inhibitors of mammalian G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

p21 is a universal inhibitor of cyclin kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human breast carcinoma cells by prostaglandin A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

Exit from G0 and entry into the cell cycle of cells expressing p21Sdi1 antisense RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

Cyclin-dependent kinases are inactivated by a combination of p21 and Thr-14/Tyr-15 phosphorylation after UV-induced DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

Prostaglandin A2 blocks the activation of G1 phase cyclin-dependent kinase without altering mitogen-activated protein kinase stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

New functional activities for the p21 family of CDK inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

The biochemistry of P-glycoprotein-mediated multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

Differential activation of peroxisome proliferator-activated receptors by eicosanoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

Metabolic dehydration of prostaglandin E2 and cellular uptake of the dehydration product: correlation with prostaglandin E2-induced growth inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

Adjuvant effects of antineoplastic prostaglandins to cisplatin in nude mice bearing human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

Cell growth inhibition by antitumor prostaglandin and its modulation by MRP/GS-X pump

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.29.18522

21 January 2018

Identifiers

DOI

10.1074/JBC.273.29.18522

1 reference

6 February 2018

PubMed ID

9660822

1 reference

6 February 2018